Skip to main content
Midas Edge

DarioHealth Corp

For the period ended Mar 31, 2024. Filed May 15, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 15, 2024

DRIO$2.06-13.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Interim Statements of Stockholders’ Equity

INTERIM STATEMENTS OF STOCKHOLDERS’ EQUITY** (UNAUDITED)**

​​​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Additional · ​ · ​ · ​ · ​ · Total
​ · ​ · Common Stock · ​ · Preferred Stock · ​ · paid-in · ​ · Accumulated · ​ · stockholders’
Three Months Ended March 31, 2024 · ​ · Number · ​ · Amount · ​ · Number · ​ · Amount · ​ · capital · ​ · deficit · ​ · equity
Balance as of December 31, 2023 (audited)27,191,849$318,959$*)-$407,502$(349,361)$58,144
​​​​​​​​​​​​​​​​​​​​
Exercise of options2,021​*)-—​—​*)-​—​—
Deemed dividend related to issuance of preferred stock—​——​—​2,034​(2,034)​—
Issuance of warrants to service providers—​——​—​27​—​27
Conversion of prefunded warrants to common Stock400,000​*)-—​—​—​—​—
Stock-based compensation1,845,870​*)-—​—​6,831​—​6,831
Issuance of preferred stock, net of issuance cost​—​​—​22,422​​*)-​​20,206​​​​​20,206
Net loss—​——​—​—​(7,175)​(7,175)
​​​​​​​​​​​​​​​​​​​​
Balance as of March 31, 2024 (unaudited)29,439,740​$341,381​$*)-​$436,600​$(358,570)​$78,033
​​​​​​​​​​​​​​​​​​​​
​​​​​​​​​​​​Additional​​​​Total
​​Common Stock​Preferred Stock​paid-in​Accumulated​stockholders’
Three Months Ended March 31, 2023​Number​Amount​Number​Amount​capital​deficit​equity
Balance as of December 31, 2022 (audited)25,724,470$33,567$*)-$365,846$(285,850)$79,999
​​​​​​​​​​​​​​​​​​​​
Issuance of warrants to service providers—​——​—​630​—​630
Stock-based compensation147,243​——​—​4,226​—​4,226
Conversion of preferred stock to common stock3,582​*)-(10)​*)-​—​—​—
Net loss—​——​—​—​(12,825)​(12,825)
​​​​​​​​​​​​​​​​​​​​
Balance as of March 31, 2023 (unaudited)25,875,295​$33,557​$*)-​$370,702​$(298,675)​$72,030
​​​​​​​​​​​​​​​​​​​​

*) Represents an amount lower than $1.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.